{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:53:37Z","timestamp":1791842017532,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T00:00:00Z","timestamp":1629676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T00:00:00Z","timestamp":1629676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The overexpression of sodium-glucose cotransporter 2 (SGLT2) in diabetic kidneys has been reported. It has also been established that the diabetic glomerular endothelium expresses the toll-like receptors TLR2 and TLR4. The present study aims to examine the renal SGLT2 induction by the TLR2\/4 ligand\n                      <jats:italic>Porphyromonas<\/jats:italic>\n                      (\n                      <jats:italic>P.<\/jats:italic>\n                      )\n                      <jats:italic>gingivalis<\/jats:italic>\n                      lipopolysaccharide (Pg-LPS) in mouse diabetic nephropathy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Immunohistochemical study and tissue RT-PCR analyses were performed on mouse kidneys in streptozotocin (STZ)-induced diabetic ICR mice (STZ-ICR), in healthy ICR mice administered Pg-LPS (LPS-ICR), and in diabetic ICR mouse kidneys with Pg-LPS-induced nephropathy (LPS-STZ).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In the quantitative analysis of blood sugar levels, the mean time to reach 600\u2009mg\/dl was shorter in the LPS-STZ than in the STZ-ICR kidneys. The rise in blood glucose levels was significantly steeper in the LPS-STZ than in the STZ-ICR kidneys. According to these data the LPS-STZ model suggests a marked glucose intolerance. The expression of SGLT2 was significantly stronger in the whole of the renal parenchyma of the LPS-STZ than in the LPS-ICR or in the STZ-ICR. The expression of SGLT2 was observed both in the renal tubules and around the renal tubules, and in the glomeruli of the LPS-STZ kidneys. In the analysis by tissue real-time PCR and cell ELISA, the expression of the SGLT2 gene and protein was significantly stronger in the LPS-STZ than in the LPS-ICR or in the STZ-ICR. There were no differences in the renal SGLT2 production in the LPS-ICR and the STZ-ICR kidneys.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Abnormally high renal expression of SGLT2 occurs in diabetic kidneys with\n                      <jats:italic>P. gingivalis<\/jats:italic>\n                      LPS. Periodontitis may be an exacerbating factor in diabetic nephropathy as well as in diabetes.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-021-02506-8","type":"journal-article","created":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T15:02:53Z","timestamp":1629730973000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Overexpression of SGLT2 in the kidney of a P. gingivalis LPS-induced diabetic nephropathy mouse model"],"prefix":"10.1186","volume":"22","author":[{"given":"Koichiro","family":"Kajiwara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,23]]},"reference":[{"issue":"13","key":"2506_CR1","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1056\/NEJMra1005073","volume":"366","author":"DA Antonetti","year":"2012","unstructured":"Antonetti DA, Klein R, Gardner TW. Mechanisms of disease: diabetic retinopathy. N Engl J Med. 2012;366(13):1227\u201339. https:\/\/doi.org\/10.1056\/NEJMra1005073.","journal-title":"N Engl J Med"},{"issue":"12","key":"2506_CR2","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/CJN.11491116","volume":"12","author":"RZ Alicic","year":"2017","unstructured":"Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, Progress, and possibilities. Clin J Am Soc Nephrol. 2017;12(12):2032\u201345. https:\/\/doi.org\/10.2215\/CJN.11491116.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"2506_CR3","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.2337\/db08-0564","volume":"57","author":"MR Dasu","year":"2008","unstructured":"Dasu MR, Devaraj S, Zhao L, Hwang DH, Jialal I. High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Diabetes. 2008;57(11):3090\u20138. https:\/\/doi.org\/10.2337\/db08-0564.","journal-title":"Diabetes"},{"issue":"8","key":"2506_CR4","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1161\/ATVBAHA.111.228924","volume":"31","author":"S Devaraj","year":"2011","unstructured":"Devaraj S, Tobias P, Kasinath BS, Ramsamooj R, Afify A, Jialal I. Knockout of toll-like receptor-2 attenuates both the pro-inflammatory state of diabetes and incipient diabetic nephropathy. Arterioscler Thromb Vasc Biol. 2011;31(8):1796\u2013804. https:\/\/doi.org\/10.1161\/ATVBAHA.111.228924.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"2506_CR5","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000317023","volume":"32","author":"F Li","year":"2010","unstructured":"Li F, Yang N, Zhang L, Tan H, Huang B, Liang Y, et al. Increased expression of toll-like receptor 2 in rat diabetic nephropathy. Am J Nephrol. 2010;32(2):179\u201386. https:\/\/doi.org\/10.1159\/000317023.","journal-title":"Am J Nephrol"},{"issue":"1","key":"2506_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1681\/ASN.2010111210","volume":"23","author":"M Lin","year":"2012","unstructured":"Lin M, Yiu WH, Wu HJ, Chan LY, Leung JC, Au WS, et al. Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy. J Am Soc Nephrol. 2012;23(1):86\u2013102. https:\/\/doi.org\/10.1681\/ASN.2010111210.","journal-title":"J Am Soc Nephrol"},{"key":"2506_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1152\/ajprenal.00398.2012","volume":"305","author":"H Mudaliar","year":"2013","unstructured":"Mudaliar H, Pollock C, Komala MG, Chadban S, Wu H, Panchapakesan U. The role of toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules. Am J Physiol Renal Physiol. 2013;305:143\u201354.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"2506_CR8","doi-asserted-by":"publisher","first-page":"861","DOI":"10.2337\/dc09-1799","volume":"33","author":"MR Dasu","year":"2010","unstructured":"Dasu MR, Devaraj S, Park S, Jialal I. Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care. 2010;33(4):861\u20138. https:\/\/doi.org\/10.2337\/dc09-1799.","journal-title":"Diabetes Care"},{"issue":"6","key":"2506_CR9","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.jdiacomp.2014.07.003","volume":"28","author":"I Jialal","year":"2014","unstructured":"Jialal I, Major AM, Devaraj S. Global toll-like receptor 4 knockout results in decreased renal inflammation, fibrosis and podocytopathy. J Diabetes Complicat. 2014;28(6):755\u201361. https:\/\/doi.org\/10.1016\/j.jdiacomp.2014.07.003.","journal-title":"J Diabetes Complicat"},{"key":"2506_CR10","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1152\/ajprenal.00319.2012","volume":"303","author":"H Kaur","year":"2012","unstructured":"Kaur H, Chien A, Jialal I. Hyperglycemia induces toll like receptor 4 expression and activity in mouse mesangial cells: relevance to diabetic nephropathy. Am J Physiol Renal Physiol. 2012;303:1145\u201350.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"2506_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10456-008-9093-5","volume":"11","author":"JR van Beijnum","year":"2008","unstructured":"van Beijnum JR, Buurman WA, Griffioen AW. Convergence and amplification of TLR and receptor for RAGE signaling pathways via high mobility group B1. Angiogenesis. 2008;11(1):91\u20139. https:\/\/doi.org\/10.1007\/s10456-008-9093-5.","journal-title":"Angiogenesis"},{"issue":"1","key":"2506_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1196\/annals.1447.063","volume":"1150","author":"FS Wong","year":"2008","unstructured":"Wong FS, Wen L. Toll-like receptors and diabetes. Ann N Y Acad Sci. 2008;1150(1):123\u201332. https:\/\/doi.org\/10.1196\/annals.1447.063.","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"2506_CR13","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1400183","volume":"1","author":"Y Feng","year":"2015","unstructured":"Feng Y, Yang S, Ma Y, Bai XY, Chen X. Role of toll-like receptors in diabetic renal lesions in a miniature pig model. Sci Adv. 2015;1(5):e1400183. https:\/\/doi.org\/10.1126\/sciadv.1400183.","journal-title":"Sci Adv"},{"issue":"1","key":"2506_CR14","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1124\/pr.114.010090","volume":"68","author":"S Goulopoulou","year":"2016","unstructured":"Goulopoulou S, McCarthy CG, Webb RC. Toll-like receptors in the vascular system: sensing the dangers within. Pharmacol Rev. 2016;68(1):142\u201367. https:\/\/doi.org\/10.1124\/pr.114.010090.","journal-title":"Pharmacol Rev"},{"issue":"5","key":"2506_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni.1863","volume":"11","author":"T Kawai","year":"2010","unstructured":"Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nat Immunol. 2010;11(5):373\u201384. https:\/\/doi.org\/10.1038\/ni.1863.","journal-title":"Nat Immunol"},{"key":"2506_CR16","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.intimp.2018.04.004","volume":"59","author":"VK Kumar","year":"2018","unstructured":"Kumar VK. Toll-like receptors in immunity and inflammatory diseases: past, present, and future. Int Immunopharmacol. 2018;59:391\u2013412.","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"2506_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097985","volume":"9","author":"J Ma","year":"2014","unstructured":"Ma J, Chadban SJ, Zhao CY, Chen X, Kwan T, Panchapakesan U, et al. TLR4 activation promotes podocyte injury and interstitial fibrosis in diabetic nephropathy. PLoS One. 2014;9(5):e97985. https:\/\/doi.org\/10.1371\/journal.pone.0097985.","journal-title":"PLoS One"},{"issue":"9","key":"2506_CR18","doi-asserted-by":"publisher","first-page":"5041","DOI":"10.1128\/IAI.72.9.5041-5051.2004","volume":"72","author":"RP Darveau","year":"2004","unstructured":"Darveau RP, Pham TT, Lemley K, Reife RA, Bainbridge BW, Coats SR, et al. Porphyromonas gingivalis lipopolysaccharide contains multiple lipid a species that functionally interact with both toll-like receptors 2 and 4. Infect Immun. 2004;72(9):5041\u201351. https:\/\/doi.org\/10.1128\/IAI.72.9.5041-5051.2004.","journal-title":"Infect Immun"},{"issue":"4","key":"2506_CR19","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1128\/IAI.01036-12","volume":"81","author":"S Jain","year":"2013","unstructured":"Jain S, Coats SR, Chang AM, Darveau RP. A novel class of lipoprotein lipase-sensitive molecules mediates toll-like receptor 2 activation by Porphyromonas gingivalis. Infect Immun. 2013;81(4):1277\u201386. https:\/\/doi.org\/10.1128\/IAI.01036-12.","journal-title":"Infect Immun"},{"issue":"14","key":"2506_CR20","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1161\/CIRCULATIONAHA.112.134379","volume":"126","author":"EO Weinberg","year":"2012","unstructured":"Weinberg EO, Genco CA. Directing TRAF-ic: cell-specific TRAF6 signaling in chronic inflammation and atherosclerosis. Circulation. 2012;126(14):1678\u201380. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.134379.","journal-title":"Circulation"},{"issue":"7","key":"2506_CR21","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1161\/hc0702.104178","volume":"105","author":"L Li","year":"2002","unstructured":"Li L, Messas E, Batista EL Jr, Levine RA, Amar S. Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation. 2002;105(7):861\u20137. https:\/\/doi.org\/10.1161\/hc0702.104178.","journal-title":"Circulation"},{"issue":"6","key":"2506_CR22","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.3390\/ijms20061414","volume":"20","author":"D Liccardo","year":"2019","unstructured":"Liccardo D, Cannavo A, Spagnuolo G, Ferrara N, Cittadini A, Rengo C, et al. Periodontal disease: a risk factor for diabetes and cardiovascular disease. Int J Mol Sci. 2019;20(6):1414. https:\/\/doi.org\/10.3390\/ijms20061414.","journal-title":"Int J Mol Sci"},{"key":"2506_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1034\/j.1600-0757.2001.22250103.x","volume":"25","author":"RI Garcia","year":"2001","unstructured":"Garcia RI, Henshaw MM, Krall EA. Relationship between periodontal disease and systemic health. Periodontol 2000. 2001;25:21\u201336.","journal-title":"Periodontol 2000"},{"issue":"8","key":"2506_CR24","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3109\/00016357.2015.1007480","volume":"73","author":"I Olsen","year":"2015","unstructured":"Olsen I. From the Acta prize lecture 2014: the periodontal-systemic connection seen from a microbiological standpoint. Acta Odontol Scand. 2015;73(8):563\u20138. https:\/\/doi.org\/10.3109\/00016357.2015.1007480.","journal-title":"Acta Odontol Scand"},{"issue":"3","key":"2506_CR25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S1532-3382(12)70006-4","volume":"12","author":"J Otomo-Corgel","year":"2012","unstructured":"Otomo-Corgel J, Pucher JJ, Rethman MP, Reynolds MA. State of the science: chronic periodontitis and systemic health. J Evid Based Dent Pract. 2012;12(3):20\u20138. https:\/\/doi.org\/10.1016\/S1532-3382(12)70006-4.","journal-title":"J Evid Based Dent Pract"},{"issue":"12","key":"2506_CR26","doi-asserted-by":"publisher","first-page":"3790","DOI":"10.1182\/blood.V97.12.3790","volume":"97","author":"A Lourbakos","year":"2001","unstructured":"Lourbakos A, Yuan Y, Jenkins AL, Travis J, Andrade-Goordon P, Santulli R, et al. Activation of protease-activated receptors by gingipains from Porphyromonas gingivalis leads to platelet aggregation: a new trait in microbial pathogenicity. Blood. 2001;97(12):3790\u20137. https:\/\/doi.org\/10.1182\/blood.V97.12.3790.","journal-title":"Blood"},{"issue":"18","key":"2506_CR27","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1001\/archinte.160.18.2749","volume":"160","author":"T Wu","year":"2000","unstructured":"Wu T, Trevisan M, Genco RJ, Dorn JP, Falkner KL, Sempos CT. Periodontal disease and risk of cerebrovascular disease. The first national health and nutrition examination survey and its follow-up study. Arch Intern Med. 2000;160(18):2749\u201355. https:\/\/doi.org\/10.1001\/archinte.160.18.2749.","journal-title":"Arch Intern Med"},{"issue":"1","key":"2506_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1267\/ahc.13002","volume":"46","author":"S Takata","year":"2013","unstructured":"Takata S, Sawa Y, Uchiyama T, Ishikawa H. Expression of toll-like receptor 4 in glomerular endothelial cells under diabetic conditions. Acta Histochem Cytochem. 2013;46(1):35\u201342. https:\/\/doi.org\/10.1267\/ahc.13002.","journal-title":"Acta Histochem Cytochem"},{"issue":"5","key":"2506_CR29","doi-asserted-by":"publisher","first-page":"e97165","DOI":"10.1371\/journal.pone.0097165","volume":"9","author":"Y Sawa","year":"2014","unstructured":"Sawa Y, Takata S, Hatakeyama Y, Ishikawa H, Tsuruga E. Expression of toll-like receptor 2 in glomerular endothelial cells and promotion of diabetic nephropathy by Porphyromonas gingivalis lipopolysaccharide. PLoS One. 2014;9(5):e97165. https:\/\/doi.org\/10.1371\/journal.pone.0097165.","journal-title":"PLoS One"},{"issue":"1","key":"2506_CR30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13098-017-0271-8","volume":"9","author":"K Kajiwara","year":"2017","unstructured":"Kajiwara K, Takata S, To TT, Takara T, Hatakeyama Y, Tamaoki S, et al. The promotion of nephropathy by Porphyromonas gingivalis lipopolysaccharide via toll-like receptors. Diabetol Metab Syndr. 2017;9(1):73. https:\/\/doi.org\/10.1186\/s13098-017-0271-8.","journal-title":"Diabetol Metab Syndr"},{"issue":"12","key":"2506_CR31","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.2337\/diabetes.54.12.3427","volume":"54","author":"H Rahmoune","year":"2005","unstructured":"Rahmoune H, Thompson PW, Ward JM, Smith CD, Hong G, Brown J. Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes. Diabetes. 2005;54(12):3427\u201334. https:\/\/doi.org\/10.2337\/diabetes.54.12.3427.","journal-title":"Diabetes"},{"issue":"4","key":"2506_CR32","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1210\/er.2010-0029","volume":"32","author":"MA Abdul-Ghani","year":"2011","unstructured":"Abdul-Ghani MA, Norton L, Defronzo RA. Role of sodium-glucose cotransporter 2 (SGLT 2) inhibitors in the treatment of type 2 diabetes. Endocr Rev Endocr Rev. 2011;32(4):515\u201331. https:\/\/doi.org\/10.1210\/er.2010-0029.","journal-title":"Endocr Rev Endocr Rev"},{"issue":"10","key":"2506_CR33","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.metabol.2014.06.018","volume":"63","author":"JP Wilding","year":"2014","unstructured":"Wilding JP. The role of the kidneys in glucose homeostasis in type 2 diabetes: clinical implications and therapeutic significance through sodium glucose co-transporter 2 inhibitors. Metabolism. 2014;63(10):1228\u201337. https:\/\/doi.org\/10.1016\/j.metabol.2014.06.018.","journal-title":"Metabolism"},{"key":"2506_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/ndt\/gfz237","volume":"35","author":"JL G\u00f3rriz","year":"2020","unstructured":"G\u00f3rriz JL, Navarro-Gonz\u00e1lez JF, Ortiz A, Vergara A, Nu\u00f1ez J, Jacobs-Cach\u00e1 C, et al. Sodium-glucose cotransporter 2 inhibition: towards an indication to treat diabetic kidney disease. Nephrol Dial Transplant. 2020;35:13\u201323.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"2506_CR35","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00232-001-0036-y","volume":"182","author":"S Vestri","year":"2001","unstructured":"Vestri S, Okamoto MM, de Freitas HS, Santos RAD, Nunes MT, Morimatsu M, et al. Changes in sodium or glucose filtration rate modulate expression of glucose transporters in renal proximal tubular cells of rat. J Membr Biol. 2001;182(2):105\u201312. https:\/\/doi.org\/10.1007\/s00232-001-0036-y.","journal-title":"J Membr Biol"},{"key":"2506_CR36","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1016\/j.diabres.2008.11.003","volume":"83","author":"NM Tabatabai","year":"2009","unstructured":"Tabatabai NM, Sharma M, Samuel S, Blumenthal SS, Petering DH. Enhanced expressions of sodium-glucose cotransporters in the kidneys of diabetic Zucker rats. Diabetes Res Clin Pract. 2009;83:e27\u201330 Therefore, increased tubular reabsorption may be due to the SGLT2 upregulation which contributes to the glucose reabsorption.","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"2506_CR37","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1210\/en.2007-1088","volume":"149","author":"HS Freitas","year":"2008","unstructured":"Freitas HS, Anh\u00ea GF, Melo KF, Okamoto MM, Oliveira-Souza M, Bordin S, et al. Na(+)-glucose transporter-2 messenger ribonucleic acid expression in kidney of diabetic rats correlates with glycemic levels: involvement of hepatocyte nuclear factor-1\u03b1 expression and activity. Endocrinology. 2008;149(2):717\u201324. https:\/\/doi.org\/10.1210\/en.2007-1088.","journal-title":"Endocrinology"},{"issue":"1","key":"2506_CR38","first-page":"6","volume":"41","author":"MD Mann","year":"1991","unstructured":"Mann MD, Crouse DA, Prentice D. Appropriate animal numbers in biomedical research in light of animal welfare consideration. Lab Anim Sci. 1991;41(1):6\u201314.","journal-title":"Lab Anim Sci"},{"key":"2506_CR39","volume-title":"Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2 Diabetologia 2018; 61","author":"C Ghezzi","year":"2087","unstructured":"Ghezzi C, Loo DDF, Wright EM. Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2 Diabetologia 2018; 61; 2087-2097."},{"issue":"1","key":"2506_CR40","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/jcp.26851","volume":"234","author":"H Yaribeygi","year":"2018","unstructured":"Yaribeygi H, Butler AE, Atkin SL, Katsiki N, Sahebkar A. Sodium-glucose cotransporter 2 inhibitors and inflammation in chronic kidney disease: possible molecular pathways. J Cell Physiol. 2018;234(1):223\u201330. https:\/\/doi.org\/10.1002\/jcp.26851.","journal-title":"J Cell Physiol"},{"issue":"13","key":"2506_CR41","doi-asserted-by":"publisher","first-page":"5335","DOI":"10.1074\/jbc.M117.779520","volume":"292","author":"XX Wang","year":"2017","unstructured":"Wang XX, Levi J, Luo Y, Myakala K, Herman-Edelstein M, Qiu L, et al. SGLT2 protein expression is increased in human diabetic nephropathy: sglt2 protein inhibition decreases renal lipid accumulation, inflammation, and the development of nephropathy in diabetic mice. J Biol Chem. 2017;292(13):5335\u201348. https:\/\/doi.org\/10.1074\/jbc.M117.779520.","journal-title":"J Biol Chem"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02506-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-021-02506-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02506-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T15:03:52Z","timestamp":1629731032000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-021-02506-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,23]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2506"],"URL":"https:\/\/doi.org\/10.1186\/s12882-021-02506-8","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,23]]},"assertion":[{"value":"4 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. The animal experimental procedures were prepared following the ARRIVE guidelines. The protocol of the experiments for animal use was approved by the Animal Experiment Committee of Fukuoka Dental College (No. 19010).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors state that there are no potential conflicts of interest. The organizations funding the research had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"287"}}